Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.

Literature DB >> 29607136

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.

Peter L Thompson¹, S Mark Nidorf¹.

Abstract

Entities: Chemical Disease

Year: 2018 PMID： 29607136 PMCID： PMC5864670 DOI： 10.21037/jtd.2018.01.119

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

20 in total

1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors: Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal: N Engl J Med Date: 2017-08-27 Impact factor: 91.245

Review 2. Anti-inflammatory therapies for cardiovascular disease.

Authors: Paul M Ridker; Thomas F Lüscher
Journal: Eur Heart J Date: 2014-05-26 Impact factor: 29.983

Review 3. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

Authors: Renata Micha; Fumiaki Imamura; Moritz Wyler von Ballmoos; Daniel H Solomon; Miguel A Hernán; Paul M Ridker; Dariush Mozaffarian
Journal: Am J Cardiol Date: 2011-08-17 Impact factor: 2.778

Review 4. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.

Authors: F Salvo; A Fourrier-Réglat; F Bazin; P Robinson; N Riera-Guardia; M Haag; A P Caputi; N Moore; M C Sturkenboom; A Pariente
Journal: Clin Pharmacol Ther Date: 2011-04-06 Impact factor: 6.875

Review 5. Novel anti-inflammatory therapies for the treatment of atherosclerosis.

Authors: Razi Khan; Vincent Spagnoli; Jean-Claude Tardif; Philippe L L'Allier
Journal: Atherosclerosis Date: 2015-04-18 Impact factor: 5.162

6. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Authors: Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn
Journal: Lancet Date: 2017-08-27 Impact factor: 79.321

7. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

Authors: Brendan M Everett; Aruna D Pradhan; Daniel H Solomon; Nina Paynter; Jean Macfadyen; Elaine Zaharris; Milan Gupta; Michael Clearfield; Peter Libby; Ahmed A K Hasan; Robert J Glynn; Paul M Ridker
Journal: Am Heart J Date: 2013-05-03 Impact factor: 4.749

Review 8. Methotrexate for treating rheumatoid arthritis.

Authors: Maria Angeles Lopez-Olivo; Harish R Siddhanamatha; Beverley Shea; Peter Tugwell; George A Wells; Maria E Suarez-Almazor
Journal: Cochrane Database Syst Rev Date: 2014-06-10

9. Low-dose colchicine for secondary prevention of cardiovascular disease.

Authors: Stefan M Nidorf; John W Eikelboom; Charley A Budgeon; Peter L Thompson
Journal: J Am Coll Cardiol Date: 2012-12-19 Impact factor: 24.094

Review 10. Colchicine for prevention of cardiovascular events.

Authors: Lars G Hemkens; Hannah Ewald; Viktoria L Gloy; Armon Arpagaus; Kelechi K Olu; Mark Nidorf; Dominik Glinz; Alain J Nordmann; Matthias Briel
Journal: Cochrane Database Syst Rev Date: 2016-01-27

11 in total

Review 1. Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis.

Authors: Le-Chun Ou; Shan Zhong; Jing-Song Ou; Jin-Wei Tian
Journal: Acta Pharmacol Sin Date: 2020-05-26 Impact factor: 6.150

Review 2. Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics.

Authors: Julie T Marchesan; Mustafa Saadat Girnary; Kevin Moss; Eugenia Timofeev Monaghan; Grant Joseph Egnatz; Yizu Jiao; Shaoping Zhang; Jim Beck; Karen V Swanson
Journal: Periodontol 2000 Date: 2020-02 Impact factor: 7.589

Review 3. The role of inflammation in hypertension: novel concepts.

Authors: David M Patrick; Justin P Van Beusecum; Annet Kirabo
Journal: Curr Opin Physiol Date: 2020-10-13

4. Machine learning and statistical approaches for classification of risk of coronary artery disease using plasma cytokines.

Authors: Seema Singh Saharan; Pankaj Nagar; Kate Townsend Creasy; Eveline O Stock; James Feng; Mary J Malloy; John P Kane
Journal: BioData Min Date: 2021-04-15 Impact factor: 2.522

Review 5. The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.

Authors: Dori Abel; Stacy P Ardoin; Mark Gorelik
Journal: Pediatr Rheumatol Online J Date: 2021-02-16 Impact factor: 3.054

Review 6. Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control.

Authors: Tsvetelina V Velikova; Plamena P Kabakchieva; Yavor S Assyov; Tsvetoslav А Georgiev
Journal: Biomed Res Int Date: 2021-09-13 Impact factor: 3.411

7. The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.

Authors: Jinglin Mo; Zimo Chen; Jie Xu; Anxin Wang; Xia Meng; Xingquan Zhao; Hao Li; Shouling Wu; Yongjun Wang
Journal: Aging (Albany NY) Date: 2020-06-16 Impact factor: 5.682